CLINICAL_TRIALS
trial_result
· 2017-08-24
Clinical Trial Update: Study of GSK1363089 in Metastatic Gastric Cancer [Phase 2]
Summary
The Phase 2 trial of GSK1363089 in metastatic gastric cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Gastrointestinal Tract | Phase 2 | Status: COMPLETED | Results posted: 2017-08-24